Published in J Virol on August 17, 2011
Herpes virus fusion and entry: a story with many characters. Viruses (2012) 2.05
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A (2013) 1.04
Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry. J Virol (2011) 0.91
Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle. J Virol (2012) 0.86
Detailed study of the interaction between human herpesvirus 6B glycoprotein complex and its cellular receptor, human CD134. J Virol (2014) 0.83
Features of Human Herpesvirus-6A and -6B Entry. Adv Virol (2012) 0.81
Herpesvirus 6 glycoproteins B (gB), gH, gL, and gQ are necessary and sufficient for cell-to-cell fusion. J Virol (2013) 0.79
Identification of the human herpesvirus 6A gQ1 domain essential for its functional conformation. J Virol (2013) 0.78
Human Herpesvirus 6A U14 Is Important for Virus Maturation. J Virol (2015) 0.78
Maturation of human herpesvirus 6A glycoprotein O requires coexpression of glycoprotein H and glycoprotein L. J Virol (2015) 0.78
Roseolovirus molecular biology: recent advances. Curr Opin Virol (2014) 0.76
Determinants of Human CD134 Essential for Entry of Human Herpesvirus 6B. J Virol (2015) 0.75
Complement Evasion Strategies of Viruses: An Overview. Front Microbiol (2017) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature (2007) 11.73
Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques (2006) 5.91
HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell (2009) 4.63
Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med (2002) 4.33
Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol (2000) 4.09
Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J Virol (1998) 3.98
Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology (2001) 3.82
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A (2005) 3.34
The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09
Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature (2003) 2.77
Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol (1998) 2.71
CD46 is a cellular receptor for human herpesvirus 6. Cell (1999) 2.67
Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol (1989) 2.58
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol (2007) 2.53
Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol (2006) 2.45
Epstein-Barr virus entry. J Virol (2007) 2.28
Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci U S A (2004) 2.19
Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells. J Gen Virol (2000) 2.19
Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol (1991) 2.16
HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A (2008) 1.79
Variations in the replication and antigenic properties of human herpesvirus 6 strains. J Infect Dis (1990) 1.70
Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem (1995) 1.59
Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion. J Virol (2005) 1.56
UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions. J Virol (2008) 1.42
Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology (2007) 1.39
Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol (2004) 1.37
Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications. Rev Med Virol (2010) 1.30
Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD. J Virol (2009) 1.26
Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology (1993) 1.24
Understanding HSV-1 entry glycoproteins. Rev Med Virol (2007) 1.22
Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J Virol (2004) 1.20
Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol (2009) 1.19
Receptors and immune sensors: the complex entry path of human cytomegalovirus. Trends Cell Biol (2004) 1.19
Monoclonal antibodies to glycoprotein B differentiate human herpesvirus 6 into two clusters, variants A and B. J Gen Virol (1993) 1.14
Recent topics related to human herpesvirus 6 cell tropism. Cell Microbiol (2009) 1.12
Functional analysis of glycoprotein L (gL) from rhesus lymphocryptovirus in Epstein-Barr virus-mediated cell fusion indicates a direct role of gL in gB-induced membrane fusion. J Virol (2009) 1.10
The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J Virol (2003) 1.08
Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J Gen Virol (2002) 1.07
Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. Virology (2010) 1.07
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. In Vivo (2009) 0.94
Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform. J Immunol (2006) 0.89
Human herpesvirus-6 entry into host cells. Future Microbiol (2010) 0.88
Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients. Int J Hematol (2002) 0.86
Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells. J Gen Virol (2009) 0.85
The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines. J Virol (2010) 0.84
Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells. J Gen Virol (2007) 0.78
SOCS-1 participates in negative regulation of LPS responses. Immunity (2002) 3.39
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol (2002) 2.05
Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis (2009) 1.60
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol (2011) 1.50
Insomnia and depression during protective isolation in patients with hematological disorders. Intern Med (2010) 1.47
Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis (2002) 1.40
Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc Natl Acad Sci U S A (2009) 1.37
Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol (2004) 1.37
Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol (2004) 1.36
Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol (2003) 1.34
Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol (2004) 1.34
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol (2002) 1.31
Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic (2008) 1.31
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine (2004) 1.27
Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J Virol (2004) 1.20
High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood (2002) 1.17
The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood (2007) 1.16
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum Gene Ther (2007) 1.13
Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells (2009) 1.12
The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J Virol (2003) 1.08
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. Virus Res (2002) 1.07
Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J Gen Virol (2002) 1.07
Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. Virology (2010) 1.07
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J Virol (2004) 1.05
CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A (2013) 1.04
Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus. J Virol (2006) 1.01
Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol (2010) 1.00
Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol (2007) 0.96
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine (2007) 0.95
The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation. J Virol (2012) 0.95
Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. J Virol (2005) 0.95
Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J Virol (2007) 0.94
Human herpesvirus 6 envelope cholesterol is required for virus entry. J Gen Virol (2006) 0.92
Identification of human herpesvirus 6 latency-associated transcripts. J Virol (2002) 0.91
Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility. J Virol Methods (2006) 0.91
Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine (2003) 0.91
Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay. J Infect Dis (2008) 0.91
Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry. J Virol (2011) 0.91
Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains. Virology (2010) 0.90
A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. Virology (2004) 0.90
Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation. J Gene Med (2008) 0.90
Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J Gen Virol (2004) 0.89
Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. J Infect Dis (2003) 0.89
Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient. J Clin Immunol (2012) 0.89
Human herpesvirus-6 entry into host cells. Future Microbiol (2010) 0.88
Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine (2009) 0.88
Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology (2009) 0.87
Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H. J Gen Virol (2006) 0.87
Development of varicella vaccine. J Infect Dis (2008) 0.87
Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Vaccine (2007) 0.86
Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection. Clin Vaccine Immunol (2012) 0.86
Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle. J Virol (2012) 0.86
Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study. J Epidemiol (2015) 0.86
A community-based survey of varicella-zoster virus-specific immune responses in the elderly. J Clin Virol (2012) 0.85
Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J Med Virol (2002) 0.85
Efficient osteoblast differentiation from mouse bone marrow stromal cells with polylysin-modified adenovirus vectors. Biochem Biophys Res Commun (2008) 0.85
Human herpesvirus-6A gQ1 and gQ2 are critical for human CD46 usage. Microbiol Immunol (2014) 0.84
Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Vaccine (2007) 0.84
DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine. Vaccine (2008) 0.84
Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line. J Med Virol (2002) 0.84
Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol (2003) 0.84
Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology (2008) 0.84
Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors. J Virol (2005) 0.84
The seroprevalence of human herpesvirus 8 infection in the Thai population. Southeast Asian J Trop Med Public Health (2002) 0.82